Stock screenerAll disclosures →
EDGAR →
OBIO
Conviction 42HealthcareScan · Thu, Jun 25, 2026Three outside down
OBIO$3.91-1.88%
ResistanceSupportVol 14Insider buyInsider sell2
2
2
Vol MA14 304.11K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price3.91
Change-1.88%
Gap-1.26%
Rel volume4.85×
Avg volume272.23K
Avg $ vol1.08M
SMA 203.96
SMA 504.03
SMA 2003.99
Price vs 50-3.20%
Price vs 200-2.15%
MA stackmixed
50/200 cross—
Supertrenddown · 4.41
RSI (14)46
MACD hist0.00
MACD cross—
Stoch %K / %D27 / 47
ADX (14)13
+DI / −DI13 / 18
RSI divergence—
MACD divergence—
ATR %+4.89%
ADR %4.59%
52w high5.35
52w low2.35
From 52w high-27.01%
Above 52w low+66.17%
New 52w highNo
SqueezeOn · 29d
Bollinger width7.90%
%B0.32
Donchian pos33.75%
Donchian high4.17
Donchian low3.77
AVWAP (52w high)4.21
vs AVWAP high-7.33%
AVWAP (52w low)4.04
vs AVWAP low-3.40%
OBV trendFlat
Chaikin MF (20)-0.26
Today vs 20d4.85×
Avg vol (14d)304.11K
Avg vol (20d)272.23K
Avg $ vol (20d)1.08M
Market cap233.83M
RS 3m (vs SPY)-26.85%
RS 6m (vs SPY)-16.24%
RS line new highNo
Trend template3/8
Technical rank30.7
1 week+0.90%
1 month-1.64%
3 months-14.55%
6 months-11.45%
1 year+21.27%
YTD-9.40%
P/E-4.44
P/B2.34
P/S6.98
P/FCF-4.73
EPS-1.11
Div yield—
ROE-52.83%
ROA-52.36%
Debt/Eq0.15
Current7.03
EV/EBITDA-4.28
Gross margin—
Net margin-157.40%
Rev growth1169.22%
EPS growth13.64%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value220.47M
Revenue110K
Net income-20.69M
Gross profit—
Free cash flow-49.45M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out59.88M
Employees86
ListedFri, Jan 27, 2023
Free float29.71M
Float %49.6%
Short interest948.25K
Days to cover3.8d
Short volume45.9%
Squeeze score44 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.33 vs −$0.40
Last surprise+17.5% beat
Setup gradeD
Conviction42 / 100
Pattern quality—
Tech rank30.7 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree outside down
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in OBIO
No recent disclosed trades by Congress in OBIO. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in OBIO · 6 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Cleary Chris Director · Common Stock, par value $0.0001 per share · 2026-06-24 | Tax | 3.51K | — | 2026-06-24 | 2026-06-25 |
Fain Eric S Director · Common Stock · 2026-06-24 | Tax | 4.26K | — | 2026-06-24 | 2026-06-25 |
Mack John Prosper Director · Common Stock · 2026-06-24 | Tax | 3.51K | — | 2026-06-24 | 2026-06-25 |
Pacitti David Director · Common Stock · 2026-06-24 | Tax | 3.78K | — | 2026-06-24 | 2026-06-25 |
Connealy Pamela Ann Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 21.28K | — | 2026-06-23 | 2026-06-25 |
Fain Eric S Director · Common Stock, par value $0.0001 per share ("Common Stock") · 2026-06-23 | Grant | 17.33K | — | 2026-06-23 | 2026-06-25 |
Pacitti David Director · Common Stock, par value $0.0001 per share ("Common Stock") · 2026-06-23 | Grant | 17.33K | — | 2026-06-23 | 2026-06-25 |
Fain Eric S Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 21.28K | — | 2026-06-23 | 2026-06-25 |
Mack John Prosper Director · Common Stock, par value $0.0001 per share ("Common Stock") · 2026-06-23 | Grant | 34.65K | — | 2026-06-23 | 2026-06-25 |
Pacitti David Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 21.28K | — | 2026-06-23 | 2026-06-25 |
SEC filings
EDGAR filings in OBIO · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.